You are here

April 23, 2019

AdvaMed Applauds NTAP Provisions in CMS Proposed Rule

WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on CMS’s FY 2020 Inpatient Prospective Payment System proposed rule: 

“This proposed rule is a significant step forward in providing patient access to truly life-changing technologies. The language captures the importance that CMS Administrator Verma has placed on these innovations, and the role they play in treating human suffering while addressing the challenges facing our health care system. We commend her hard work and that of her staff.  

“We are pleased that this rule reflects several of AdvaMed’s priorities, including increasing funding for new technology add-on payments (NTAP), and making it easier for breakthrough technologies to access the Medicare program. This will help ensure that hospitals and patients have access to breakthrough innovations and care, and further incentivize transformational technologies. 

“We look forward to reviewing the proposed rule in more detail, and working closely with CMS on additional ways to facilitate greater efficiencies in the coverage and payment process.” 

# # # 

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit